Dr. Theresa Visarius, Immunophotonics Vice President of Business Development and Managing Director of Immunophotonics Switzerland will be attending Bio-Europe 2022 October 24th to 26th.

Lu Alleruzzo, Co-Founder & CEO, at Immunophotonics, Inc., will be attending the BioPharm America 2022 conference in Boston on September 28 & 29th.

Lu Alleruzzo, Co-Founder & CEO, at Immunophotonics, Inc. will be attending the RESI Boston 2022 Partnering Platform, September 21st & 22nd in Boston at the Westin Copley Place.

Dr. Theresa Visarius, Immunophotonics Vice President Business Development and Managing Director of the Swiss subsidiary IPS Biopharma AG will be at the SACHS Associates 22nd Annual Biotech in Europe Forum for Global Partnering and Investment on Wednesday and Thursday, September 21st & 22nd.

Tomas Hode, PhD, Co-Founder, CIO, and President at Immunophotonics, Inc. attended the Cardiovascular and Interventional Radiology Society of Europe (CIRSE) Conference on September 10 – 14, 2022 in Barcelona, Spain.

Lu Alleruzzo, Co-Founder & CEO at Immunophotonics, Inc. attended the European Society of Medical Oncology (ESMO) Congress in Paris, France on September 9 – 13, 2022.

Immunophotonics would like to congratulate Ashley Hoover and Kaili Liu lead authors from the University of Oklahoma and to the co-authors Tomas Hode, Wei Chen, and Sui Kit “Samuel” Lam on the T-Cell Paper publication in Clinical and Translational Medicine July 2022 issue. Check out this pivotal publication on how immunological remodeling of T-cells can...

Dr. Theresa Visarius, VP of Business Development at Immunophotonics, Inc. will be attending 2022 Swiss MedTech Day on Tuesday, June 14, 2022 in Kursaal Bern Switzerland.

Tomas Hode, PhD, Co-Founder, CIO, and President at Immunophotonics, Inc. will be attending the Society of Interventional Radiology Annual Scientific Meeting (SIR) in Boston, MA June 11 – 16, 2022.